Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1995 1
1998 1
2000 1
2002 2
2004 1
2005 1
2006 1
2009 1
2010 1
2012 4
2013 4
2014 5
2015 5
2016 3
2017 4
2018 5
2019 3
2021 5
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Coronary artery disease, autosomal dominant 2"
Page 1
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.
Koopal C, Marais AD, Westerink J, Visseren FL. Koopal C, et al. J Clin Lipidol. 2017 Jan-Feb;11(1):12-23.e1. doi: 10.1016/j.jacl.2016.10.001. Epub 2016 Oct 13. J Clin Lipidol. 2017. PMID: 28391878 Review.
Familial dysbetalipoproteinemia (FD) is a genetic disorder of lipoprotein metabolism associated with an increased risk for premature cardiovascular disease. In about 10% of the cases, FD is caused by autosomal dominant mutations in the apolipoprotein E gene ( …
Familial dysbetalipoproteinemia (FD) is a genetic disorder of lipoprotein metabolism associated with an increased risk for premature cardiov …
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
Loh WJ, Chang X, Aw TC, Phua SK, Low AF, Chan MY, Watts GF, Heng CK. Loh WJ, et al. Atherosclerosis. 2022 May;349:160-165. doi: 10.1016/j.atherosclerosis.2021.11.018. Epub 2021 Nov 26. Atherosclerosis. 2022. PMID: 34887076
BACKGROUND AND AIMS: The role of Lp(a) in multi-ethnic Asian populations with coronary artery disease (CAD) has not been well established. The aims of this study were (i) to investigate whether Lp(a) is a predictor of CAD, and (ii) amongst patients with CAD, …
BACKGROUND AND AIMS: The role of Lp(a) in multi-ethnic Asian populations with coronary artery disease (CAD) has not bee …
Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.
Ugovšek S, Šebeštjen M. Ugovšek S, et al. Biomolecules. 2021 Dec 24;12(1):26. doi: 10.3390/biom12010026. Biomolecules. 2021. PMID: 35053174 Free PMC article. Review.
Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD and DAS. Lp(a) levels are genetically determinated in an autosomal domina …
Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aor …
Genetics of sudden cardiac death in the young.
Saenen JB, Van Craenenbroeck EM, Proost D, Marchau F, Van Laer L, Vrints CJ, Loeys BL. Saenen JB, et al. Clin Genet. 2015 Aug;88(2):101-13. doi: 10.1111/cge.12519. Epub 2014 Nov 22. Clin Genet. 2015. PMID: 25307320 Review.
Moreover, over the last decade a prominent genetic contribution to the pathogenesis of SCD has been unveiled. As many inherited cardiac diseases show an autosomal dominant pattern of inheritance, the risk of carrying the same inherited predisposition is a real conce …
Moreover, over the last decade a prominent genetic contribution to the pathogenesis of SCD has been unveiled. As many inherited cardiac dise …
Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
Reddy LL, Shah SAV, Ashavaid TF. Reddy LL, et al. Indian Heart J. 2022 Jan-Feb;74(1):1-6. doi: 10.1016/j.ihj.2021.11.185. Epub 2021 Dec 4. Indian Heart J. 2022. PMID: 34875256 Free PMC article. Review.
Familial hypercholesterolemia (FH) is a common autosomal dominant disorder that affects 1 in 250-500 individuals globally. ...There are only 6 genetic studies in India of the total mutations, 32% are LDLR mutations, 4% are ApoB, 2% are PCSK9 mutations and the …
Familial hypercholesterolemia (FH) is a common autosomal dominant disorder that affects 1 in 250-500 individuals globally. ... …
Aortic valve and arterial calcification in patients with familial hypercholesterolemia.
Waluś-Miarka M, Polus A, Idzior-Waluś B. Waluś-Miarka M, et al. Kardiol Pol. 2024;82(2):144-155. doi: 10.33963/v.phj.98945. Epub 2024 Feb 13. Kardiol Pol. 2024. PMID: 38348620 Free article. Review.
Heterozygous familial hypercholesterolemia (heFH) is an autosomal dominant lipid metabolism disorder. Its prevalence is 1:250-1:300 people in the population. Patients with heFH have an up to 13-fold increased risk of premature coronary artery diseas …
Heterozygous familial hypercholesterolemia (heFH) is an autosomal dominant lipid metabolism disorder. Its prevalence is 1:250- …
Conditions and Factors Associated With Spontaneous Coronary Artery Dissection (from a National Population-Based Cohort Study).
Krittanawong C, Kumar A, Johnson KW, Luo Y, Yue B, Wang Z, Bhatt DL. Krittanawong C, et al. Am J Cardiol. 2019 Jan 15;123(2):249-253. doi: 10.1016/j.amjcard.2018.10.012. Epub 2018 Oct 30. Am J Cardiol. 2019. PMID: 30477805
The pathophysiology of spontaneous coronary artery dissection (SCAD) is heterogeneous, associated with systemic arteriopathies and inflammatory diseases, and often compounded by environmental precipitants, genetics, or stressors. ...Among 66,360 patients diagnosed w …
The pathophysiology of spontaneous coronary artery dissection (SCAD) is heterogeneous, associated with systemic arteriopathies …
Pediatric Drug Development Studies for Familial Hypercholesterolemia Submitted to the US Food and Drug Administration Between 2007 and 2020.
Park K, Vishnevetskaya K, Vaidyanathan J, Burckart GJ, Green DJ. Park K, et al. J Clin Pharmacol. 2022 Mar;62(3):397-408. doi: 10.1002/jcph.1973. Epub 2021 Oct 19. J Clin Pharmacol. 2022. PMID: 34562277 Review.
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder of lipoprotein metabolism that leads to an increased risk of developing atherosclerosis and coronary artery disease. ...Of 10 trials with 8 products in pediatric FH sub …
Familial hypercholesterolemia (FH) is an autosomal dominant genetic disorder of lipoprotein metabolism that leads to an increa …
Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects.
Smelt AH, de Beer F. Smelt AH, et al. Semin Vasc Med. 2004 Aug;4(3):249-57. doi: 10.1055/s-2004-861492. Semin Vasc Med. 2004. PMID: 15630634 Review.
Homozygosity for APOE*2 (1 in 170 persons) causes FD or type III hyperlipoproteinemia in less than 20% of the adult APOE*2 homozygotes. ...The disorder is associated with peripheral and coronary artery disease. Additional gene and environmental …
Homozygosity for APOE*2 (1 in 170 persons) causes FD or type III hyperlipoproteinemia in less than 20% of the adult APOE*2 hom …
Early echocardiographic signs of cardiovascular affection in pediatric familial hypercholesterolemia.
Ibrahim H, Saad H, Abdelaziz O, Abdelmohsen G. Ibrahim H, et al. Eur J Pediatr. 2023 Oct;182(10):4389-4397. doi: 10.1007/s00431-023-05094-x. Epub 2023 Jul 21. Eur J Pediatr. 2023. PMID: 37477701 Free PMC article.
Familial hypercholesterolemia (FH) is a rare autosomal dominant genetic disorder caused by defective low-density lipoprotein (LDL) receptors or abnormal apolipoprotein B. ...What is Known: Familial hypercholesterolemia (FH) in adults is associated with accelerated a …
Familial hypercholesterolemia (FH) is a rare autosomal dominant genetic disorder caused by defective low-density lipoprotein ( …
46 results